Who Will Benefit From Metformin?

IF 22.5 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2022-05-24 DOI:10.1001/jamaoncol.2022.1911

J. Mortimer, V. Seewaldt

引用次数: 2

查看原文本刊更多论文

谁将从二甲双胍中受益？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.